Product Images Anastrozole

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Anastrozole NDC 50090-5002 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - anastrozole 01

Chemical Structure - anastrozole 01

Figure 1 - anastrozole 02

Figure 1 - anastrozole 02

Figure 2 - anastrozole 03

Figure 2 - anastrozole 03

The given text seems to be a graph that represents the proportion of patients who are alive and disease-free with respect to the treatment of breast cancer. The graph presents a comparison between treatment with the drug Anastrozole and Tamoxifen. The horizontal axis represents the time in months, and the vertical axis represents the proportion alive and disease-free. The number of patients at risk is also shown for both types of treatment.*

Figure 3 - anastrozole 04

Figure 3 - anastrozole 04

This appears to be a truncated Kaplan-Meier curve showing the time to event (in months) for patients who received randomized treatment with either anastrozole or tamoxifen. The number of patients at risk is also shown for various months. The text seems to have some errors and inconsistent characters, making parts of it unreadable.*

Figure 4 - anastrozole 05

Figure 4 - anastrozole 05

This is a Kaplan-Meier survival curve for patients being randomized to receive Anastrozole or Tamoxifen. The horizontal axis represents the time to an event in months, while the vertical axis represents the proportion of patients with event-free survival. The text contains some data points and the number of patients at risk, but the details of the study are not available.*

Figure 5 - anastrozole 06

Figure 5 - anastrozole 06

This is a medical graph that shows the progression of a randomized treatment method using two drugs, Anastrozole and Tamoxifen, for an unspecified condition. The x-axis of the graph shows the time to progression in months, ranging from 0 to 32 months. The y-axis shows the proportion of patients who did not progress. The graph suggests that the proportion of patients who did not progress remained relatively stable throughout the course of the treatment.*

Figure 6 - anastrozole 07

Figure 6 - anastrozole 07

This is a medical chart depicting the time to progression in months for randomized treatment on ANASTROZOLE and TAMOXIFEN. However, the rest of the text is not available for interpretation.*

Label Image - lbl500905002

Label Image - lbl500905002

This appears to be a product label for a medication called "AstroZOLE 1mg", with 30 tablets per container, and the product number is 6198-0. The medication may be used to treat hormone receptor positive breast cancer. The label also includes an address for "Stone AT" at 6810 7 Decces, but it is unclear what this refers to without further context.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.